by Martin Armstrong, Armstrong Economics:
A recent measure from the Biden Administration touted as a solution to lower prescription drug costs has a more sinister motive. The Bayh–Dole Act or Patent and Trademark Law Amendments Act of 1980 permitted researchers to own the patents of their products developed through government funds. The legislation permitted “march-in” rights that enabled these agencies to grant a license on their patents to third parties. For the first time in four decades, the federal government wants to invoke this measure as they are losing both money and power amid this private wave.